Function of the Integrin a6fJl in Metastatic Breast Carcinoma Cells Assessed by Expression of a Dominant-Negative Receptor'

نویسندگان

  • Leslie M. Shaw
  • Celia Chao
  • Ulla M. Wewer
  • Arthur M. Mercurio
چکیده

The involvement of the a6@3lintegrin, a laminin receptor, in breast carcInoma progression needs to be addressed rigorously. We report that a human breast carcinoma cell lIne, MDA-MB.435, known to be highly Invasive and metastatic, expresses three potential Integrin laminin recep tors: a2fil, [email protected], and a6fil, but uses only a6@3lto mediate adhesion and migration on laminin matrices. To Investigate the contribution of a6@J1 to the aggressive behavior of these cells, we developed a dominant-negative strategy for knocking out a6fil function that involved expression of a cytoplasmic domain deletion mutant of the @34integrin subunit by cDNA transfection. Stable transfectants of MDA-MB-435 cells that expressed this mutant fi4 subunit were inhibited dramatically in their ability to adhere and migrate on laminin matrices, and their capacity to Invade Matrigel was reduced significantly. These findings support the hypothesis that a6@31is important for breast cancer progression. Moreover, this approach is a powerful method that should be useful in assessing the role of a6fil in other cells.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bioinformatics-Based Prediction of FUT8 as a Therapeutic Target in Estrogen Receptor-Positive Breast Cancer

Abstract Introduction: Estrogen receptor-positive (ER-positive) breast cancer is a subgroup of breast tumors that is more likely to respond to hormone therapy. ER-positive and ER- negative breast cancers tend to show different patterns of metastasis because of different signaling cascade and genes that are activated by estrogen response. Genetic factors can contribute to high rates of metastas...

متن کامل

Bioinformatics-Based Prediction of FUT8 as a Therapeutic Target in Estrogen Receptor-Positive Breast Cancer

Abstract Introduction: Estrogen receptor-positive (ER-positive) breast cancer is a subgroup of breast tumors that is more likely to respond to hormone therapy. ER-positive and ER- negative breast cancers tend to show different patterns of metastasis because of different signaling cascade and genes that are activated by estrogen response. Genetic factors can contribute to high rates of metastas...

متن کامل

بررسی ایمونوهیستوشیمیائی Expression گیرنده پروژسترون در پلئومورفیک آدنوما و آدنوئیدسیستیک کارسینومای غده بزاقی

Background and Aim: The hormone receptor status in breast cancer has been pivotal in determining the likelihood of response to hormonal manipulation. Tumors which are both estrogen and progesterone receptor positive are much more likely to respond to anti-hormone therapy than negative tumors. There is well-established similarity between breast tissue and salivary glands. The aim of this study w...

متن کامل

Bone morphogenic protein receptor type 1a (BMPR1A) and Caveolin-1 associated with trastuzumab resistance of breast cancer cells

Trastuzumab is a specific monoclonal antibody used for therapeutic of the human epidermal growth factor receptor 2 (HER-2) -positive metastatic breast cancer. But, resistance to trastuzumab is a major obstacle in clinical efficiency.  During the past years, several studies have been done to find the mechanisms contributing to trastuzumab resistance. Previous studies have highlighted that bone m...

متن کامل

Androgen Receptor Analysis in Relation to Estrogen and Progesterone Receptors as well as Histological Grade for Ductal Carcinoma In Situ of the Breast

Background and Objective: Since the advent of mammography screening, ductal carcinoma in situ (DCIS) of the breast has been diagnosed increasingly. In contrast to the situation in invasive breast carcinoma, there are only a few reports on androgen receptor (AR) status in DCIS and few reports on estrogen ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006